drugset / Trial / NCT02016885

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

NCT02016885

Phase 2 Completed 198 enrolled Journey Medical Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.

Timeline

Start
2013-11
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule 1 % Topical
Subject Glycopyrrolate Small molecule 2 % Topical
Subject Glycopyrrolate Small molecule 3 % Topical
Subject Glycopyrrolate Small molecule 4 % Topical

Indications

No indication recorded.